Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. - Test2 - elhamkhani - TriplyDB

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

http://www.wikidata.org/entity/Q27686808

about

Biomarkers of Parkinson's disease: present and future Gut Feelings About α-Synuclein in Gastrointestinal Biopsies: Biomarker in the Making?Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice Is Cell Death Primary or Secondary in the Pathophysiology of Idiopathic Parkinson's Disease?Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Oculo-Visual Dysfunction in Parkinson's Disease.Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease Arguing against the proposed definition changes of PD How Research on Human Progeroid and Antigeroid Syndromes Can Contribute to the Longevity Dividend Initiative Are Upper-Body Axial Symptoms a Feature of Early Parkinson's Disease?Default mode network differences between rigidity- and tremor-predominant Parkinson's disease Diagnosing and treating neurogenic orthostatic hypotension in primary care.Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia Premotor and nonmotor features of Parkinson's disease.Motor output variability, deafferentation, and putative deficits in kinesthetic reafference in Parkinson's disease MDS clinical diagnostic criteria for Parkinson's disease.MDS research criteria for prodromal Parkinson's disease.Eryptosis as a marker of Parkinson's disease Unbiased approaches to biomarker discovery in neurodegenerative diseases Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.Nursing interventions for rehabilitation in Parkinson's disease: cross mapping of terms.Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease Motor Subtype as a Predictor of Future Working Memory Performance in Idiopathic Parkinson's Disease.Propagated but Topologically Distributed Forebrain Neurons Expressing Alpha-Synuclein in Aged Macaques "Gunslinger's gait": a new cause of unilaterally reduced arm swing.Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysis Pathological α-synuclein distribution in subjects with coincident Alzheimer's and Lewy body pathology.Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease.Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.Inflammation in Parkinson's disease: role of glucocorticoids.Cinnamamide Derivatives for Central and Peripheral Nervous System Disorders--A Review of Structure-Activity Relationships.Advanced stages of PD: interventional therapies and related patient-centered care.The relevance of pre-motor symptoms in Parkinson's disease.The Concept of Prodromal Parkinson's Disease.Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson's disease.The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system ɑ-Synuclein strains and the variable pathologies of synucleinopathies.

P2860

Q24170134-B80E0B1E-E231-47BD-A06E-4527A671BE29 Q26769620-C5F4B9DE-8528-474A-A0DD-6399D4A72F24 Q26773064-DA719571-4965-4EDE-98A4-3B4A8ABFAC98 Q26801733-BE775EAC-43B5-4657-9F6A-15615918333C Q27322513-2E82E8C7-8A48-4109-ACF1-69A707EDC879 Q27691337-1F86C15F-4B2B-492B-ADA6-CC1595411AEA Q28071861-E6FF72E0-E49C-4E2C-88DF-11BB578A9B7B Q28079237-2133A1E1-701C-4FDD-85C6-7B89359CE97B Q28601451-2203274C-3592-4504-8E12-A9D005B7B00A Q30372617-AE5C66C6-3F1C-471A-B2D2-DB1CF41B4C38 Q30843485-C5DC3DF7-CE67-4106-8893-6D9C8F82575F Q33165773-F732AD29-E9F0-4FBD-9EE7-A3C25A59C9BB Q33562458-2074425B-2527-4505-9005-918565B47804 Q34274224-F205CF95-22E7-43FD-BB60-761620F1A082 Q34377411-142E3930-72C9-4E59-9AE5-737E6631C88F Q34498274-93D77909-BED4-44D0-B1B4-C7F64917F0B4 Q34498279-083BF9D4-F781-48C7-AEA7-5E718F05D121 Q34585744-2B434D00-74A4-4EEC-96D4-CF6AD228261C Q34625918-FAD5E9DC-047F-4CE8-B452-0BB3F9C2D282 Q34627859-4EAC8208-DBA8-483F-A00C-97009E586C77 Q34678262-9076E85C-20FA-4745-A345-C1ED9F9D01A0 Q35211066-E8A02CB1-90D1-4447-BA67-6B5A3EFD5FE7 Q35442728-90F20B7F-9E33-43E5-9E3E-28EF409B9852 Q35970595-6643DCCB-6884-4AB6-9545-5327B10F5A4C Q36197708-605A4FD3-2C52-41D5-B097-7A5F1F6733AF Q36369299-06836442-911F-4DB2-8FFB-AA9511CA6F89 Q36419572-B41A5187-FD7F-4531-94A6-30AB7C4FB14E Q36581696-263A9074-C516-42D9-A84B-4095AD82D3FC Q37129119-3C3D6BD0-65E5-4D8A-AB95-DED33472026F Q37141684-6186EA1A-E7EB-4D99-AFDE-BF7F642FA8FC Q37274056-370B6B72-EBC8-418F-B82B-F2E1E11FFB14 Q37516494-47234BF8-E7BE-41D7-8C79-A8F304209321 Q38425458-CBEA6E9A-39F9-4296-92FA-35C5170F233C Q38530238-681C4B6D-8075-42F7-9948-CD4C90721B1A Q38542180-3B91850C-F823-4AE8-9425-610909C1763B Q38594857-89456271-09D0-4605-B538-803017B07F33 Q38612230-A684F739-4AD9-4C0C-99A8-09EF475DB342 Q38636630-D5C699FA-FB6B-4B28-A26B-4424170B9AD1 Q38752945-E5D22B22-6936-4368-99A7-BC6FA1629FFE Q38753941-CADCF30E-9D4C-473F-9D8C-3C27196DAD13

P2860

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

http://www.wikidata.org/entity/Q27686808

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Time to redefine PD? Introduct ...... nition of Parkinson's disease.

@ast

Time to redefine PD? Introduct ...... nition of Parkinson's disease.

@en

Time to redefine PD? Introduct ...... nition of Parkinson's disease.

@nl

type

label

Time to redefine PD? Introduct ...... nition of Parkinson's disease.

@ast

Time to redefine PD? Introduct ...... nition of Parkinson's disease.

@en

Time to redefine PD? Introduct ...... nition of Parkinson's disease.

@nl

prefLabel

Time to redefine PD? Introduct ...... nition of Parkinson's disease.

@ast

Time to redefine PD? Introduct ...... nition of Parkinson's disease.

@en

Time to redefine PD? Introduct ...... nition of Parkinson's disease.

@nl

P1433

Q27686808-DFCE93CF-D63A-4EB2-92BB-13557B498D87

P1476

Q27686808-FCBFE75D-4A87-43AB-8034-B10A1DB4D1DA

P2093

Q27686808-1DB7E29C-933D-4F62-BA56-DDAF87D2729F

Q27686808-6100454D-0324-43D5-9CF6-AEC22FC68C62

Q27686808-8A7856D7-0F90-4D99-9B98-6A14B7A1BEE1

Q27686808-C5D0D718-C707-4563-A75D-B1B24A2D3EAF

Q27686808-E339272C-0105-4879-A6B9-0C43807E3845

Q27686808-F235FC9F-8261-4444-BE8D-370D287E6B77

P275

Q27686808-C2AB95AD-A964-479F-B56D-EFAE6601A49A

P2860

Q27686808-05FC7716-1648-43A5-962F-A2B599B1CCA7

Q27686808-0E1AB308-8654-4810-9172-4B81BC162934

Q27686808-10087CD2-BC9C-4D35-9C91-D366B01AE5D8

Q27686808-1C49355A-5CF5-4187-8588-C10481056D6F

Q27686808-1ECADCBD-EBCA-4B7D-BF49-3EB2166F80FF

Q27686808-20FD2427-AA80-449A-B7ED-B3B597177974

Q27686808-23229FB6-301C-4CEA-9483-DBF531F8DB86

Q27686808-27FA812D-4486-443C-B26E-02D8865CF3E4

Q27686808-27FC5099-BC36-4E6E-BEF4-E5953C57BDE1

Q27686808-2E23D321-55CE-4F06-B966-8F0973B8589C

P304

Q27686808-0ACFEF2E-AB86-49D2-8EB5-9DE3DE531FDA

P31

Q27686808-33E229F2-08D3-4511-82C9-60E3AD79E6B3

Q27686808-68175E46-CCEA-4124-BF86-974AC9EB13A5

P3181

Q27686808-19E20517-6987-497B-BCAB-C88E397F9130

P356

Q27686808-953CB67C-A021-4F36-9D82-F01157D20206

P407

Q27686808-84CFD3A9-D1AE-4F42-8851-D811DE9FF0E3

P433

Q27686808-CC4BB2E6-0702-40EC-90C8-BF4B2CFE28BA

P478

Q27686808-9B692176-D330-40C4-B9DB-5B5B69D92B89

P50

Q27686808-11C098D4-2600-4AC8-A86E-EDB1FBEA9520

Q27686808-1396112D-FEBA-4E84-B473-7BC22AEFC8B2

Q27686808-397DA6BD-F124-485C-809D-C32511183B90

Q27686808-3D4FD7E7-598F-4CB6-8CA7-51E532BF4797

Q27686808-4F3797D7-8BE0-46FC-9B08-3C7890E4342A

Q27686808-75A9D3D2-9F3F-4E27-8057-AAB1C00B112D

Q27686808-9E27CEB1-2667-43D1-999A-F26C61F0A97F

Q27686808-B27C9132-76F2-49E3-94C6-0BEE311D62C2

Q27686808-B743CB3E-C7EF-49E8-9925-4614A49628ED

Q27686808-C46ABBE4-CBF7-41D6-9E2A-CC29C8C9D07B

P5008

Q27686808-DB131FBF-A9DA-4C0E-AF2E-505AC9032C48

P577

Q27686808-55C2CD06-9EFF-4487-86F9-7BA821934239

Q27686808-B855EF24-FD17-442D-B240-C58C051A0686

P698

Q27686808-FB02D83F-0B91-4B9B-BBD6-C813B2EE0EDD

P921

Q27686808-A263522A-838C-48F5-AE3C-36B618A99B95

P932

Q27686808-01E0BCFE-BD4B-40A4-8CF1-E50CCD230456

P3181

P356

P1433

Movement Disorders

P1476

Time to redefine PD? Introduct ...... nition of Parkinson's disease.

@en

P2093

Glenda M. Halliday

http://www.w3.org/2001/XMLSchema#string

José Obeso

http://www.w3.org/2001/XMLSchema#string

Kenneth Marek

http://www.w3.org/2001/XMLSchema#string

Matthew Stern

http://www.w3.org/2001/XMLSchema#string

Piu Chan

http://www.w3.org/2001/XMLSchema#string

Ronald B. Postuma

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Staging of brain pathology related to sporadic Parkinson's disease

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Bowel movement frequency in late-life and incidental Lewy bodies.

Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach.

The diagnosis of Parkinson's disease.

A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes.

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease.

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

P304

454-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3390837

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/MDS.25844

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang H. Oertel

Günther Deuschl

John Anthony Hardy

Bastiaan R Bloem

P5008

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24619848

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4204150

http://www.w3.org/2001/XMLSchema#string